15 | $NERV LL1.26 ML3.9 now | znewcar1 | 12/04/2023 12:27:43 PM |
14 | $NERV 69% v53,2M c10.19 f5,568M Hod11.14 ML5.59 | znewcar1 | 06/28/2023 6:57:44 PM |
13 | $NERV Hod9.97 | znewcar1 | 06/28/2023 10:16:25 AM |
12 | $NERV Hod7.7 S6.5 and every .5 | znewcar1 | 05/10/2023 9:44:28 AM |
11 | $NERV 22% v940K c4.59 f5,340M H4.97 | znewcar1 | 05/02/2023 4:43:24 PM |
10 | $NERV 27% v578K c2.31 f5,340M H2.51 ML1.5 | znewcar1 | 04/11/2023 5:55:42 PM |
9 | $NERV 21% v1,3M c2.28 f5,340M H2.99 ML1.26 | znewcar1 | 01/11/2023 6:20:06 PM |
8 | $nerv BO14 | znewcar1 | 10/14/2022 4:33:03 PM |
7 | $NERV 19% v878K c12.46 f5,340M H12.54 | znewcar1 | 10/11/2022 4:37:36 PM |
6 | NERV 58% v62,7M c10.33 f5,34M H10.90 Haft11.53 | znewcar1 | 08/26/2022 4:27:25 PM |
5 | HOD9.6 S8.83 a whirlwind under | znewcar1 | 08/26/2022 12:29:33 PM |
4 | HOD9.4 Support in $8? | znewcar1 | 08/26/2022 12:17:57 PM |
3 | HOD9.23 | znewcar1 | 08/26/2022 12:09:07 PM |
2 | NERV HOD8. Next stop? teens? | znewcar1 | 08/26/2022 11:35:24 AM |
1 | NERV 66% v82,3M c7.51 f5,34M H8.58 ML2.51 | znewcar1 | 08/24/2022 9:00:26 PM |
Recent Articles
- BP's Anticipated Earnings Impacted by Falling Oil Prices
- VinFast Auto's Impact and Recent Developments in the EV Market
- New Dawn for Grove City College Under President Lingo's Leadership
- Connecting Cultures: ChASC5 and the Future of Diplomacy
- Understanding Market Trends: Preparing for Future Opportunities
- Unlocking America’s Hidden Resources: A Strategic Overview
- Cyabra Exposes Covert Iranian Influence Campaign Targeting UK
- Transforming Communication: The Rise of IP Telephony Solutions
- Unlocking the Future of Diabetes Care: A Comprehensive Market Outlook
- Exploring Growth in the Cryptojacking Solution Market
- AIXA Miner Boosts Crypto Earnings with Green Tech and AI
- Unlock Wealth with SAVVY MINING's Cloud Mining Solutions
- Unlocking Profits with a Revolutionary Bitcoin Mining Model
- ServiceTitan Announces Investor Session Details for Pantheon 2025
- Investors Encouraged to Join class Action Against Centene Corp
- A Decade of Cheers: Samuel Adams and Red Sox Extend Bond
- ServiceTitan's Upcoming Investor Session: What You Need to Know
- Key Polymer Announces Successful Sale of SWEPCO Division
- Eimskip Finalizes Sale of Lagarfoss to Grupo Sousa
- Virtru's Latest Funding Round Fuels Expansion in Data Security
- SINEXCEL Achieves Milestone in Global Charger Sales Leadership
- Viewbix Secures $4.5 Million in At-The-Market Private Placement
- TACA's New Strategy: Enhancing Support for Autism Families
- Regulatory Hurdles Challenge Capricor's Duchenne Therapy Plans
- AeC Honored with 2025 Award for Excellence in Customer Experience
- Visa and Mastercard: Unmatched Leaders in Payment Processing
- Join Iovance Biotherapeutics Class Action for Investor Protection
- High Hopes for Trump-Xi Summit Following Rubio's Talks
- MN8 Energy Secures $575 Million for Renewable Energy Expansion
- Boyd Gaming Divests FanDuel Stake for Strategic Growth
- Addressing the Ongoing OB/GYN Workforce Shortage Challenges
- Boqii Holding's Strategic Listing Shift and Reverse Stock Split
- Unlocking America’s Hidden Wealth: Resources for Growth
- 3D Systems Corporation Investors Urged to Act on Lawsuit Rights
- RBC Global Asset Management Reports Strong June Sales Results
- Seeking Justice for Rocket Pharmaceuticals Investors through Action
- Vestis Corporation Investors Urged to Seek Justice for Losses
- Investors Seek Justice in PepGen Inc. (PEPG) Class Action
- Investors Urged to Act on Reckitt Benckiser Group plc Lawsuit
- Important Investor Update for Fortrea Holdings Inc. - FTRE
- Organon & Co. Faces Securities Class Action: Key Insights
- Red Cat Holdings Faces Class Action Lawsuit Amid Securities Concerns
- DoubleVerify Holdings, Inc. Class Action: What You Need to Know
- WesBanco Elevates Kevin McCormack to Lead Mid-Atlantic Market
- Advocating for Healthcare Equity: The Fight Against Cuts
- Strategic Innovations and Leadership Transformation at Hapbee
- Brag House Set to Showcase Innovative Engagement on Bloomberg
- Bel Fuse Announces Q2 2025 Results Call Schedule for Investors
- Cycurion's Leadership to Address Cybersecurity Challenges
- FibroBiologics to Showcase Innovative Treatment Strategies